Several methods have been described for the determination of urinary acid mucopolysaccharides (1-4). It has been found that in normal individuals the daily urinary excretion varies with age and sex (4, 5) . A few attempts have been made to correlate urinary excretion of acid mucopolysaccharides with different disease states. Craddock and Kerby (6) have reported that patients with impairment of renal function have a urinary excretion of acid mucopolysaccharides lower than that of normal individuals. They also found no significant differences between normal individuals and diabetic patients without renal involvement. In patients with rheumatoid arthritis Badin, Schubert, and Vouras (7) have demonstrated a high plasma concentration of acid mucopolysaccharides, but there have hitherto been no data available concerning their urinary excretion. This paper presents data on the urinary excretion of acid mucopolysaccharides by patients with rheumatoid arthritis and discusses the identity of the urinary acid mucopolysaccharides excreted in this disease.
Several methods have been described for the determination of urinary acid mucopolysaccharides (1) (2) (3) (4) . It has been found that in normal individuals the daily urinary excretion varies with age and sex (4, 5) . A few attempts have been made to correlate urinary excretion of acid mucopolysaccharides with different disease states. Craddock and Kerby (6) have reported that patients with impairment of renal function have a urinary excretion of acid mucopolysaccharides lower than that of normal individuals. They also found no significant differences between normal individuals and diabetic patients without renal involvement. In patients with rheumatoid arthritis Badin, Schubert, and Vouras (7) have demonstrated a high plasma concentration of acid mucopolysaccharides, but there have hitherto been no data available concerning their urinary excretion. This paper presents data on the urinary excretion of acid mucopolysaccharides by patients with rheumatoid arthritis and discusses the identity of the urinary acid mucopolysaccharides excreted in this disease.
MATERIAL AND METHOD
The study was performed on eight patients hospitalized for active rheumatoid arthritis. All of them showed a moderately elevated erythrocyte sedimentation rate, low-grade fever, involvement of several joints, and typical radiographic alterations. All patients were untreated when the urine collection was started. Two of them, however (M.G. and P.C.), discontinued treatment a few days before the urine collection was started. Urinary acid mucopolysaccharides were determined according to the method described by Di Ferrante and Rich (4) , by which the urinary acid mucopolysaccharides are precipitated, from an aliquot of the 24-hour urine, with cetyl-trimethyl-ammonium bromide. After removal of the precipitant the glucuronic acid content of the precipitate is determined. The results in Table I and in Figure  1 In five patients (P.C., B.E., E.E., W.J., and G.A.) the urinary excretion of acid mucopolysaccharides was measured both before and during periods of oral treatment with sodium salicylate.
In order to collect an amount of urinary acid mucopolysaccharides sufficient for purification and analysis, 20 liters of pooled urine from patients with rheumatoid arthritis were adjusted to pH 5 with 2 N HCl, and 8 Gm. of cetyl-trimethyl-ammonium bromide were added. After 24 hours at 00 C., the fine precipitate present was collected, by filtration under suction, on a thin layer of Hyflo super-cel. The cake of Hyflo super-cel was then washed in a 250-ml. centrifuge bottle with several 150-ml. aliquots of 95 per cent ethyl alcohol saturated in NaCl, until the supernatant obtained after centrifugation was colorless. The sediment was dried in a desiccator, under vacuum and in presence of paraffin chips, and then extracted three times with 30 ml. of distilled water. The aqueous extract was reprecipitated with three volumes of 95 per cent ethyl alcohol saturated in NaCl.
After 24 hours at 00 C., the precipitate was collected by centrifugation, dissolved in 100 ml. of water and cleared of insoluble material by further centrifugation at 13 The paper chromatogram of the hydrolyzed urinary mucopolysaccharides from patients with rheumatoid arthritis, developed according to Hausmann's technique and stained with ninhydrin, revealed, besides a major component having the same mobility as a standard of glucosamine and galactosamine hydrochloride,' at least 10 additional components. On paper chromatography, according to Kerby (15) , and on paper electrophoresis, the urinary mucopolysaccharides from normal individuals and from patients with rheumatoid arthritis presented a similar pattern, namely a fastmoving component having a mobility similar to that of a standard of skeletal chondroitin-sulfate, and another component, migrating at a rather slower rate, with a mobility similar to that of a standard of hyaluronate. Incubation for 30 minutes with 100 turbidity reducing units of bacterial hyaluronidase produced 30 per cent depolymerization of the preparation obtained from patients with rheumatoid arthritis and 15 per cent depolymerization of the preparation obtained from normal individuals. Incubation under the same conditions, for intervals of time shorter or longer than 30 minutes, demonstrated that the last interval allowed maximal depolymerization of the substrates.
DISCUSSION
The presence in normal human urine of an acid mucopolysaccharide similar to skeletal chondroitinsulfuric acid has been demonstrated (16) . Both hyaluronic acid and chondroitinsulfuric acid have been found in normal human plasma (18) . Recently, hyaluronic acid has been isolated in a relatively large amount from the sera of two patients with reticulum cell sarcoma and neuroblastoma (19) . Considering that urinary acid mucopolysaccharides are present in urine obtained from the renal pelvis (5) and that their average molecular weight is approximately 10,0008 (16), it appears correct to assume that the urinary material derives from the similar one present in plasma.
The analytical data of Table II suggest the pos-sibility that the urinary mucopolysaccharides from normal individuals and from patients with rheumatoid arthritis are a mixture of chondroitinsulfate and hyaluronate. This possibility is supported by the following considerations: 1) 10 per cent and 35 per cent of the total hexosamine present in the preparations of urinary mucopolysaccharides from normal individuals and from patients with rheumatoid arthritis appear to be glucosamine.
2) The results of the enzymatic experiments are in good agreement with these values. In fact, incubation of aliquots of the two preparations with bacterial hyaluronidase produced respectively 15 per cent and 30 per cent depolymerization of the substrates.
3) The sulfur and the galactosamine of the two preparations are approximately in equimolar ratio. The excess of sulfur may be due to sulfur-containing amino acids from protein contaminants. Is the different ratio chondroitinsulfate/hyaluronate in the two groups of individuals merely a consequence of the different techniques used for the purification of the urinary materials, or is it a reflection of some difference, in the metabolism and/or excretion of acid mucopolysaccharides in the two groups? Analysis of several preparations of acid mucopolysaccharides obtained from normal human urine using the technique described here has demonstrated that approximately 30 per cent of the hexosamine present in them is glucosamine. Therefore, it seems correct to assume that the difference in hyaluronate content of the two preparations presented in Table II is due to the different techniques used for their purification.
The administration of sodium salicylate to patients with rheumatoid arthritis appears to reduce the previously elevated urinary excretion of acid mucopolysaccharides. No data are available on the effect of this drug on the plasma level of acid mucopolysaccharides in similar conditions. It has been reported, however, that the administration of cortisone,9 aspirin and gold, either together or separately, to patients with rheumatoid arthritis, reduces the elevated serum level of glycoproteins (20) .
Several observations seem to prove that sodium salicylate decreases the uptake of sulfate-S85 by slices of cartilage in vitro (21) and the hexosamine content of the skin in vivo (22) , effects which have been interpreted as indicative of inhibition in the synthesis of acid mucopolysaccharides produced by this drug. At present, however, it is not possible to state whether a decreased rate of synthesis is responsible for the diminution in the urinary excretion of acid mucopolysaccharides which follows the administration of salicylate to patients with rheumatoid arthritis.
SUMMARY
In patients with active, untreated rheumatoid arthritis the daily urinary excretion of acid mucopolysaccharides was higher than in normal individuals.
The administration of sodium salicylate to those patients decreased the urinary excretion of acid mucopolysaccharides.
Paper chromatography and paper electrophoresis, analytical and enzymatic data seem to indicate that the urinary acid mucopolysaccharides from normal individuals and those from patients with rheumatoid arthritis are a mixture of chondroitinsulfate and hyaluronate.
